Safety and Efficacy of Bevacizumab With Hypofractionated Stereotactic Irradiation for Recurrent Malignant Gliomas

International Journal of Radiation Oncology Biology Physics - Netherlands
doi 10.1016/j.ijrobp.2008.10.043
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Bevacizumab With Hypofractionated Stereotactic Irradiation for Recurrent Malignant Gliomas

2012English

Hypofractionated Stereotactic Re-Irradiation: Treatment Option in Recurrent Malignant Glioma

BMC Cancer
Cancer ResearchOncologyGenetics
2005English

Salvage Fractionated Stereotactic Re-Irradiation (FSRT) for Patients With Recurrent High Grade Gliomas Progressed After Bevacizumab Treatment

JHN Journal
2018English

Recurrent Malignant Gliomas

Seminars in Radiation Oncology
Cancer ResearchNuclear MedicineRadiologyImagingOncology
2014English

Efficacy of Bevacizumab Therapy in Recurrent Malignant Gliomas in Relation to the Prior Recurrence Pattern or Tumor Location

Journal of Clinical Neuroscience
MedicineSurgeryNeurologyPhysiology
2017English

Stereotactic Hypofractionated Irradiation for Metastatic, Inoperable, and Recurrent Malignancies: A Modern Necessity, Rather Than a Luxury

Journal of Radiotherapy
2014English

Second Course of Stereotactic Radiosurgery for Locally Recurrent Brain Metastases: Safety and Efficacy

PLoS ONE
Multidisciplinary
2018English

Radiosurgery and Hypofractionated Stereotactic Irradiation With Photons or Protons for Tumours of the Skull Base

2013English

Efficacy and Safety of Oxaliplatin, Bevacizumab and Oral S-1 for Advanced Recurrent Colorectal Cancer

Molecular and Clinical Oncology
Cancer ResearchOncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy